Exocure Therapeutics

A biotechnology startup company aimed at developing a therapeutic based on human exosomes for the treatment of pancreatic and breast cancer.

Health Tech & Life Sciences
Active
Pre-Funding Sakhnin, Israel Founded 2025
Website ↗
Last updated 2026-07-20
Total raised
Stage
Pre-Funding
Founded
2025
Headcount
5
HQ
Sakhnin, Israel
Sector
Health Tech & Life Sciences

About

ExoCure is developing a novel exosomal cancer treatment that addresses the flaws of conventional therapies. The company's product is an exosome-based therapy, aimed at treating breast and pancreatic cancers by selectively targeting overactive tumor pathways, while preserving healthy cells. Administered intravenously, ExoCure's therapy is designed for use as a standalone treatment or in combination with existing cancer therapies with strong potential for adaptation across additional cancer types.

Funding history · 1 round · — total

2026-02
Seed Undisclosed
Government Agency

Q&A

What is Exocure Therapeutics' primary focus?
Exocure Therapeutics is developing exosome-based cancer therapeutics designed to selectively target tumor pathways while reducing harm to healthy cells.
Which types of cancer is Exocure Therapeutics' lead program positioned to treat?
The lead program from Exocure Therapeutics is positioned for breast and pancreatic cancers.
What is the intended administration method for Exocure Therapeutics' therapy?
Exocure Therapeutics' therapy is intended for IV administration.
What is the current employee count for Exocure Therapeutics?
Exocure Therapeutics has 1-10 employees.
Who are the co-founders of Exocure Therapeutics?
The co-founders of Exocure Therapeutics are Reem Miari, who serves as Co-Founder & CEO, and Mizied Falah Mizied Falah, who is the Co-Founder & CSO.
When was Exocure Therapeutics founded?
Exocure Therapeutics was founded in September 2025.
What is Exocure Therapeutics' current funding stage?
Exocure Therapeutics is currently in the Pre-Funding stage.
Where is Exocure Therapeutics headquartered?
Exocure Therapeutics is headquartered in Sakhnin, Israel.

Team · 2

Dr. Reem Miari
Founder · CEO & Co-Founder
Dr. Mizied Falah
Founder · CSO & Co-Founder

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websiteexocure-therapeutics.com

Identifiers & details

Legal nameExocure Therapeutics Ltd.
Founded2025
Employees (exact)5

Radar intelligence

Web history (Wayback)

Domainexocure-therapeutics.com

Certificate / subdomain footprint

Subdomains1

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)517213088
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2025-09-01
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)no
Active charges / liens0
Registry events0
Registered addressאלריחאנה 9 סח'נין